Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 22
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion

  • Valls Lacalle, Laura
  • Puertas-Umbert, Lídia
  • Varona, Saray
  • Martínez-González, José
  • Rodríguez Sinovas, Antonio
  • Rodriguez, Cristina
Cardiac remodeling; Lysyl oxidase; Reperfusion injury, Remodelación cardiaca; Lisil oxidasa; Lesión por reperfusión, Remodelació cardíaca; Lisil oxidasa; Lesió de reperfusió, Lysyl oxidase (LOX) is an enzyme critically involved in collagen maturation, whose activity releases H2O2 as a by-product. Previous studies demonstrated that LOX over-expression enhances reactive oxygen species (ROS) production and exacerbates cardiac remodeling induced by pressure overload. However, whether LOX influences acute myocardial infarction and post-infarct left ventricular remodeling and the contribution of LOX to myocardial oxidative stress following ischemia-reperfusion have not been analyzed. Isolated hearts from transgenic mice over-expressing human LOX in the heart (TgLOX) and wild-type (WT) littermates were subjected to global ischemia and reperfusion. Although under basal conditions LOX transgenesis is associated with higher cardiac superoxide levels than WT mice, no differences in ROS production were detected in ischemic hearts and a comparable acute ischemia-reperfusion injury was observed (infarct size: 56.24 ± 9.44 vs. 48.63 ± 2.99% of cardiac weight in WT and TgLOX, respectively). Further, similar changes in cardiac dimensions and function were observed in TgLOX and WT mice 28 days after myocardial infarction induced by transient left anterior descending (LAD) coronary artery occlusion, and no differences in scar area were detected (20.29 ± 3.10 vs. 21.83 ± 2.83% of left ventricle). Our data evidence that, although LOX transgenesis induces baseline myocardial oxidative stress, neither ROS production, infarct size, nor post-infarction cardiac remodeling were exacerbated following myocardial ischemia-reperfusion., This work was supported by the Spanish Instituto de Salud Carlos III (ISCIII) (PI18/0919 and PI17/01397) co-financed by the European Regional Development Fund (ERDF-FEDER, a way to build Europe), the Spanish Ministerio de Ciencia e Innovación (RTI2018-094727-B-100), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2017-SGR-00333 and 2017-SGR-1807) and Fundació La Marató TV3 (grant 2015.3610). A.R.-S. has a consolidated Miguel Servet contract and L.P. is supported by a PFIS contract (ISCIII).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Citric Acid Cycle Metabolites Predict Infarct Size in Pigs Submitted to Transient Coronary Artery Occlusion and Treated with Succinate Dehydrogenase Inhibitors or Remote Ischemic Perconditioning

  • Consegal Perez, Marta
  • Núñez, Norberto
  • Barba Vert, Ignasi
  • Benito Villabriga, Begoña
  • Inserte Igual, Javier
  • Ferreira González, Ignacio
  • Rodríguez Sinovas, Antonio
  • Ruiz Meana, Marisol
Isquèmia-reperfusió; Infart de miocardi; Succinat deshidrogenasa, Isquemia-reperfusión; Infarto de miocardio; Succinato deshidrogenasa, Ischemia-reperfusion; Myocardial infarction; Succinate dehydrogenase, Succinate dehydrogenase (SDH) inhibition with malonate during reperfusion reduced myocardial infarction in animals, whereas its endogenous substrate, succinate, is detected in plasma from STEMI patients. We investigated whether protection by SDH inhibition is additive to that of remote ischemic perconditioning (RIC) in pigs submitted to transient coronary artery occlusion, and whether protective maneuvers influence plasma levels of citric acid cycle metabolites. Forty pigs were submitted to 40 min coronary occlusion and reperfusion, and allocated to four groups (controls, sodium malonate 10 mmol/L, RIC, and malonate + RIC). Plasma was obtained from femoral and great cardiac veins and analyzed by LC-MS/MS. Malonate, RIC, and malonate + RIC reduced infarct size (24.67 ± 5.98, 25.29 ± 3.92 and 29.83 ± 4.62% vs. 46.47 ± 4.49% in controls, p < 0.05), but no additive effects were detected. Enhanced concentrations of succinate, fumarate, malate and citrate were observed in controls during initial reperfusion in the great cardiac vein, and most were reduced by cardioprotective maneuvers. Concentrations of succinate, fumarate, and malate significantly correlated with infarct size. In conclusion, despite the combination of SDH inhibition during reperfusion and RIC did not result in additive protection, plasma concentrations of selected citric acid cycle metabolites are attenuated by protective maneuvers, correlate with irreversible injury, and might become a prognosis tool in STEMI patients., This research was funded by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (grants PI17/01397 and CIBERCV) and the Spanish Society of Cardiology (Proyectos de la FEC para Investigación Básica en Cardiología 2018, Sociedad Española de Cardiología), and was cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Serum Metabolomic Analysis Suggests Impairment of Myocardial Energy Production in Takotsubo Syndrome

  • Andres Villarreal, Mireia
  • Benito Villabriga, Begoña
  • Bernardo, Esther
  • Vedia, Oscar
  • Ferreira González, Ignacio
  • Barba Vert, Ignasi
  • Nuñez Gil, Ivan Javier
Acute coronary syndromes; Takotsubo syndrome, Síndromes coronarios agudos; Síndrome de Takotsubo, Síndromes coronaris aguts; Síndrome de Takotsubo, Introduction: Takotsubo syndrome is a complex entity that, although it usually has a good prognosis, can be life threatening. While recent advances have improved the knowledge of takotsubo syndrome, many aspects of its etiology still remain uncertain. Metabolomics, a hypothesis generating approach, could provide novel pathophysiology information about this disease. Methods and Results: Serum samples were obtained from takotsubo (n = 19) and acute myocardial infarction patients (n = 8) at the cath lab and, in the case of takotsubo, again once the patient had recovered, 3 months after the main event. 1H NMR spectra of the serum were acquired at 9.4T using a CPMG pulse sequence (32 ms effective delay). Supervised and unsupervised pattern recognition approaches where applied to the data. Pattern recognition was able to differentiate between takotsubo and acute myocardial infarction during the acute phase with 95% accuracy. Myocardial infarction patients showed an increase in lipid signals, a known risk factor for the disease while takotsubo patients showed a relative increase in acetate that could suggest a reduced turnover of the Krebs cycle. When comparing acute and recovered phases, we could detect an increase in alanine and creatine once patients recovered. Conclusions: Our results demonstrate that takotsubo syndrome is metabolically different than AMI, showing limited myocardial energy production capacity during the acute phase. We achieved high classification success against AMI; however, this study should be considered as a proof of concept regarding clinical application of metabolic profiling in takotsubo cardiomyopathy., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (Grants PI14/01431 and PI17/01397, SGR-1807, CIBER-CV, and CIBERESP), co-financed by the European Regional Development Fund (ERDF-FEDER, a way to build Europe).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease

  • Rodríguez Sinovas, Antonio
  • Sanchez Garcia, Jose A
  • Valls de Lacalle, Laura
  • Consegal Perez, Marta
  • Ferreira González, Ignacio
Cardiomiòcit; Connexina; Mitocondris, Cardiomiocito; Conexina; Mitocondrias, Cardiomyocyte; Connexin; Mitochondria, Connexins are a family of transmembrane proteins that play a key role in cardiac physiology. Gap junctional channels put into contact the cytoplasms of connected cardiomyocytes, allowing the existence of electrical coupling. However, in addition to this fundamental role, connexins are also involved in cardiomyocyte death and survival. Thus, chemical coupling through gap junctions plays a key role in the spreading of injury between connected cells. Moreover, in addition to their involvement in cell-to-cell communication, mounting evidence indicates that connexins have additional gap junction-independent functions. Opening of unopposed hemichannels, located at the lateral surface of cardiomyocytes, may compromise cell homeostasis and may be involved in ischemia/reperfusion injury. In addition, connexins located at non-canonical cell structures, including mitochondria and the nucleus, have been demonstrated to be involved in cardioprotection and in regulation of cell growth and differentiation. In this review, we will provide, first, an overview on connexin biology, including their synthesis and degradation, their regulation and their interactions. Then, we will conduct an in-depth examination of the role of connexins in cardiac pathophysiology, including new findings regarding their involvement in myocardial ischemia/reperfusion injury, cardiac fibrosis, gene transcription or signaling regulation., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (grants PI17/01397 and CIBERCV), and the Spanish Society of Cardiology (Proyectos de la FEC para Investigación Básica en Cardiología 2018, Sociedad Española de Cardiología), Fundació La Marató de TV3 (Nº. 201536-10) and was cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test

  • Lema, Camila
  • Aguade Bruix, Santiago
  • Consegal, Marta
  • Ferreira-Gonzalez, Ignacio
  • Barba, Ignasi
  • Andrés Villarreal, Mireia
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
Síndromes coronàries agudes; Metabolòmica, Síndromes coronarios agudos; Metabolómica, Acute coronary syndromes; Metabolomics, Cardiovascular diseases are the leading cause of death worldwide. Changes in lifestyle and/or pharmacological treatment are able to reduce the burden of coronary artery diseases (CAD) and early diagnosis is crucial for the timely and optimal management of the disease. Stress testing is a good method to measure the burden of CAD but it is time consuming and pharmacological testing may not fully mimic exercise test. The objectives of the present project were to characterize the metabolic profile of the population undergoing pharmacological and exercise stress testing to evaluate possible differences between them, and to assess the capacity of 1H NMR spectroscopy to predict positive stress testing. Pattern recognition was applied to 1H NMR spectra from serum of patients undergoing stress test and metabolites were quantified. The effects of the stress test, confounding variables and the ability to predict ischemia were evaluated using OPLS-DA. There was an increase in lactate and alanine concentrations in post-test samples in patients undergoing exercise test, but not in those submitted to pharmacological testing. However, when considering only pharmacological patients, those with a positive test result, showed increased serum lactate, that was masked by the much larger amount of lactate associated to exercise testing. In conclusion, we have established that pharmacological stress test does not reproduce the dynamic changes observed in exercise stress. Although there is promising evidence suggesting that 1H NMR based metabolomics could predict stress test results, further studies with much larger populations will be required in order to obtain a definitive answer., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (Grants PI14/01431 and PI17/01397, SGR-1807, CIBER-CV and CIBERESP), co-financed by the European Regional Development Fund (ERDF-FEDER, a way to build Europe).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Angiotensin II-induced cardiomyocyte hypertrophy: A complex response dependent on intertwined pathways, Hipertrofia cardiomiocitária induzida por angiotensina II: Uma resposta complexa dependente de vias entrelaçadas

  • Consegal Perez, Marta
  • Valls de Lacalle, Laura
  • Rodríguez Sinovas, Antonio
Hipertrofia cardiomiocitária, Hipertròfia cardiomiocitària, Cardiomyocyte hypertrophy, This study was supported by the Spanish Ministry of Economy and Competitiveness and Instituto de Salud Carlos III (PI17/01397 and CIBERCV), and cofinanced by the European Regional Development Fund (ERDF, ‘a Way to Build Europe’). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Spontaneous reperfusion enhances succinate concentration in peripheral blood from stemi patients but its levels does not correlate with myocardial infarct size or area at risk

  • Serra Creus, Bernat
  • Ojeda Ramos, Manuel Tamir
  • Carmona, Maria Angeles
  • Lidón Corbi, Rosa María
  • Inserte Igual, Javier
  • Ferreira González, Ignacio
  • Martí Aguasca, Gerard
  • Valente, Filipa
  • Ruiz Meana, Marisol
  • miro casas, elisabet
  • Rodriguez-Sinovas, Antonio
  • García del Blanco, Bruno
  • Barrabés, José A.
  • Rodríguez Palomares, Jose Fernando
  • Sambola Ayala, Antonia
  • Benito, Begoña
  • Consegal, Marta
  • Barba, Ignasi
  • Bañeras, Jordi
  • Otaegui Irurueta, Imanol
  • Bellera Gotarda, Neus
Cardiovascular biology; Diagnostic markers; Prognostic markers, Biología cardiovascular; Marcadores de diagnóstico; Marcadores pronósticos, Biologia cardiovascular; Marcadors diagnòstics; Marcadors pronòstics, Succinate is enhanced during initial reperfusion in blood from the coronary sinus in ST-segment elevation myocardial infarction (STEMI) patients and in pigs submitted to transient coronary occlusion. Succinate levels might have a prognostic value, as they may correlate with edema volume or myocardial infarct size. However, blood from the coronary sinus is not routinely obtained in the CathLab. As succinate might be also increased in peripheral blood, we aimed to investigate whether peripheral plasma concentrations of succinate and other metabolites obtained during coronary revascularization correlate with edema volume or infarct size in STEMI patients. Plasma samples were obtained from peripheral blood within the first 10 min of revascularization in 102 STEMI patients included in the COMBAT-MI trial (initial TIMI 1) and from 9 additional patients with restituted coronary blood flow (TIMI 2). Metabolite concentrations were analyzed by 1H-NMR. Succinate concentration averaged 0.069 ± 0.0073 mmol/L in patients with TIMI flow ≤ 1 and was significantly increased in those with TIMI 2 at admission (0.141 ± 0.058 mmol/L, p < 0.05). However, regression analysis did not detect any significant correlation between most metabolite concentrations and infarct size, extent of edema or other cardiac magnetic resonance (CMR) variables. In conclusion, spontaneous reperfusion in TIMI 2 patients associates with enhanced succinate levels in peripheral blood, suggesting that succinate release increases overtime following reperfusion. However, early plasma levels of succinate and other metabolites obtained from peripheral blood does not correlate with the degree of irreversible injury or area at risk in STEMI patients, and cannot be considered as predictors of CMR variables. Trial registration: Registered at www.clinicaltrials.gov (NCT02404376) on 31/03/2015. EudraCT number: 2015-001000-58., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (Grants PI17/01397 and CIBERCV) and the Spanish Society of Cardiology (Proyectos de la FEC para Investigación Básica en Cardiología 2018, Sociedad Española de Cardiología), and was cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Sex differences in the 1 H NMR metabolic profile of serum in cardiovascular risk patients

  • Barba, Ignasi|||0000-0001-9886-3776
  • Andrés Villareal, Mireia|||0000-0002-0657-5855
  • Picón, Irene
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
  • García-Dorado, David|||0000-0002-1126-1279
Personalized diagnosis and risk stratification of cardiovascular diseases would allow optimizing therapeutic strategies and lifestyle changes. Metabolomics is a promising technique for personalized diagnosis and prognosis; however, various physiological parameters, including sex, influence the metabolic profile thus hampering its translation to the clinic. Knowledge of the variation in the metabolic profile associated with sex would facilitate metabolomic translation to the clinic. The objective of the present work was to investigate the possible differences in the metabolic H NMR profile associated to sex beyond lipoproteins. H NMR spectra from whole serum and methanol deproteinized samples from 39 patients (22 males, 17 females) between 55-70 years old with suspected coronary artery disease that underwent a stress test that was considered negative where included. Deproteinized serum could be used to differentiate sex based on higher levels of lactate and glucose in women. Lipoprotein region was the most variable area of the spectra between individuals, but spectra of whole serum were able to differentiate sex based on lipoproteins. There are sex-related differences in the H NMR metabolic profile of individuals with suspected cardiovascular disease beyond lipoproteins. These findings may help the translation of metabolomics to the clinic.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Enhancing Glycolysis Protects against Ischemia-Reperfusion Injury by Reducing ROS Production

  • Beltran, Claudia
  • Pardo, Rosario
  • Bou-Teen, Diana|||0000-0003-3181-3824
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Villena, Josep A.|||0000-0002-2200-2985
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Barba, Ignasi|||0000-0001-9886-3776
After myocardial ischemia-reperfusion, fatty acid oxidation shows fast recovery while glucose oxidation rates remain depressed. A metabolic shift aimed at increasing glucose oxidation has shown to be beneficial in models of myocardial ischemia-reperfusion. However, strategies aimed at increasing glucose consumption in the clinic have provided mixed results and have not yet reached routine clinical practice. A better understanding of the mechanisms underlying the protection afforded by increased glucose oxidation may facilitate the transfer to the clinic. The purpose of this study was to evaluate if the modulation of reactive oxygen species (ROS) was involved in the protection afforded by increased glucose oxidation. Firstly, we characterized an H9C2 cellular model in which the use of glucose or galactose as substrates can modulate glycolysis and oxidative phosphorylation pathways. In this model, there were no differences in morphology, cell number, or ATP and PCr levels. However, galactose-grown cells consumed more oxygen and had an increased Krebs cycle turnover, while cells grown in glucose had increased aerobic glycolysis rate as demonstrated by higher lactate and alanine production. Increased aerobic glycolysis was associated with reduced ROS levels and protected the cells against simulated ischemia-reperfusion injury. Furthermore, ROS scavenger N-acetyl cysteine (NAC) was able to reduce the amount of ROS and to prevent cell death. Lastly, cells grown in galactose showed higher activation of mTOR/Akt signaling pathways. In conclusion, our results provide evidence indicating that metabolic shift towards increased glycolysis reduces mitochondrial ROS production and prevents cell death during ischemia-reperfusion injury.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

1 H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test

  • Lema, Camila
  • Andrés Villareal, Mireia|||0000-0002-0657-5855
  • Aguadé-Bruix, Santiago|||0000-0001-8617-6274
  • Consegal, Marta|||0000-0002-9201-9117
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Benito Villabriga, Begoña|||0000-0002-8668-1251
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Barba, Ignasi|||0000-0001-9886-3776
Cardiovascular diseases are the leading cause of death worldwide. Changes in lifestyle and/or pharmacological treatment are able to reduce the burden of coronary artery diseases (CAD) and early diagnosis is crucial for the timely and optimal management of the disease. Stress testing is a good method to measure the burden of CAD but it is time consuming and pharmacological testing may not fully mimic exercise test. The objectives of the present project were to characterize the metabolic profile of the population undergoing pharmacological and exercise stress testing to evaluate possible differences between them, and to assess the capacity of 1 H NMR spectroscopy to predict positive stress testing. Pattern recognition was applied to 1 H NMR spectra from serum of patients undergoing stress test and metabolites were quantified. The effects of the stress test, confounding variables and the ability to predict ischemia were evaluated using OPLS-DA. There was an increase in lactate and alanine concentrations in post-test samples in patients undergoing exercise test, but not in those submitted to pharmacological testing. However, when considering only pharmacological patients, those with a positive test result, showed increased serum lactate, that was masked by the much larger amount of lactate associated to exercise testing. In conclusion, we have established that pharmacological stress test does not reproduce the dynamic changes observed in exercise stress. Although there is promising evidence suggesting that 1 H NMR based metabolomics could predict stress test results, further studies with much larger populations will be required in order to obtain a definitive answer.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Selective Inhibition of Succinate Dehydrogenase in Reperfused Myocardium with Intracoronary Malonate Reduces Infarct Size

  • Valls-Lacalle, Laura|||0000-0002-7185-0454
  • Barba, Ignasi|||0000-0001-9886-3776
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
Inhibition of succinate dehydrogenase (SDH) with malonate during reperfusion reduces infarct size in isolated mice hearts submitted to global ischemia. However, malonate has toxic effects that preclude its systemic administration in animals. Here we investigated the effect of intracoronary malonate on infarct size in pigs submitted to transient coronary occlusion. Under baseline conditions, 50 mmol/L of intracoronary disodium malonate, but not lower concentrations, transiently reduced systolic segment shortening in the region perfused by the left anterior descending coronary artery (LAD) in open-chest pigs. To assess the effects of SDH inhibition on reperfusion injury, saline or malonate 10 mmol/L were selectively infused into the area at risk in 38 animals submitted to ischemia-reperfusion. Malonate improved systolic shortening in the area at risk two hours after 15 min of ischemia (0.18 ± 0.07 vs 0.00 ± 0.01 a.u., p = 0.025, n = 3). In animals submitted to 40 min of ischemia, malonate reduced reactive oxygen species production (MitoSOX staining) during initial reperfusion and limited infarct size (36.46 ± 5.35 vs 59.62 ± 4.00%, p = 0.002, n = 11), without modifying reperfusion arrhythmias. In conclusion, inhibition of SDH with intracoronary malonate during early reperfusion limits reperfusion injury and infarct size in pigs submitted to transient coronary occlusion without modifying reperfusion arrhythmias or contractile function in distant myocardium.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Connexins in the Heart, Regulation, Function and Involvement in Cardiac Disease

  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Sánchez García, José Antonio
  • Valls-Lacalle, Laura|||0000-0002-7185-0454
  • Consegal, Marta|||0000-0002-9201-9117
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
Connexins are a family of transmembrane proteins that play a key role in cardiac physiology. Gap junctional channels put into contact the cytoplasms of connected cardiomyocytes, allowing the existence of electrical coupling. However, in addition to this fundamental role, connexins are also involved in cardiomyocyte death and survival. Thus, chemical coupling through gap junctions plays a key role in the spreading of injury between connected cells. Moreover, in addition to their involvement in cell-to-cell communication, mounting evidence indicates that connexins have additional gap junction-independent functions. Opening of unopposed hemichannels, located at the lateral surface of cardiomyocytes, may compromise cell homeostasis and may be involved in ischemia/reperfusion injury. In addition, connexins located at non-canonical cell structures, including mitochondria and the nucleus, have been demonstrated to be involved in cardioprotection and in regulation of cell growth and differentiation. In this review, we will provide, first, an overview on connexin biology, including their synthesis and degradation, their regulation and their interactions. Then, we will conduct an in-depth examination of the role of connexins in cardiac pathophysiology, including new findings regarding their involvement in myocardial ischemia/reperfusion injury, cardiac fibrosis, gene transcription or signaling regulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Citric Acid Cycle Metabolites Predict Infarct Size in Pigs Submitted to Transient Coronary Artery Occlusion and Treated with Succinate Dehydrogenase Inhibitors or Remote Ischemic Perconditioning

  • Consegal, Marta|||0000-0002-9201-9117
  • Núñez, Norberto
  • Barba, Ignasi|||0000-0001-9886-3776
  • Benito Villabriga, Begoña|||0000-0002-8668-1251
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Inserte, Javier|||0000-0003-2283-3591
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
Succinate dehydrogenase (SDH) inhibition with malonate during reperfusion reduced myocardial infarction in animals, whereas its endogenous substrate, succinate, is detected in plasma from STEMI patients. We investigated whether protection by SDH inhibition is additive to that of remote ischemic perconditioning (RIC) in pigs submitted to transient coronary artery occlusion, and whether protective maneuvers influence plasma levels of citric acid cycle metabolites. Forty pigs were submitted to 40 min coronary occlusion and reperfusion, and allocated to four groups (controls, sodium malonate 10 mmol/L, RIC, and malonate + RIC). Plasma was obtained from femoral and great cardiac veins and analyzed by LC-MS/MS. Malonate, RIC, and malonate + RIC reduced infarct size (24.67 ± 5.98, 25.29 ± 3.92 and 29.83 ± 4.62% vs. 46.47 ± 4.49% in controls, p < 0.05), but no additive effects were detected. Enhanced concentrations of succinate, fumarate, malate and citrate were observed in controls during initial reperfusion in the great cardiac vein, and most were reduced by cardioprotective maneuvers. Concentrations of succinate, fumarate, and malate significantly correlated with infarct size. In conclusion, despite the combination of SDH inhibition during reperfusion and RIC did not result in additive protection, plasma concentrations of selected citric acid cycle metabolites are attenuated by protective maneuvers, correlate with irreversible injury, and might become a prognosis tool in STEMI patients.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Spontaneous reperfusion enhances succinate concentration in peripheral blood from stemi patients but its levels does not correlate with myocardial infarct size or area at risk

  • Consegal, Marta|||0000-0002-9201-9117
  • Barba, Ignasi|||0000-0001-9886-3776
  • García del Blanco, Bruno|||0000-0002-4527-1600
  • Otaegui, Imanol|||0000-0001-6594-3139
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Martí, Gerard
  • Serra-Vidal, Bernat|||0000-0002-2273-4801
  • Bellera Gotarda, Neus|||0000-0002-1040-0900
  • Ojeda-Ramos, Manuel
  • Valente, Filipa|||0000-0002-5569-3292
  • Carmona, Maria Ángeles|||0000-0002-9078-2178
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Sambola, Antonia
  • Lidón, Rosa María|||0000-0001-7008-2716
  • Bañeras, Jordi|||0000-0002-7395-0862
  • Barrabés, José A.|||0000-0001-7062-6277
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Benito Villabriga, Begoña|||0000-0002-8668-1251
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Inserte, Javier|||0000-0003-2283-3591
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
Succinate is enhanced during initial reperfusion in blood from the coronary sinus in ST-segment elevation myocardial infarction (STEMI) patients and in pigs submitted to transient coronary occlusion. Succinate levels might have a prognostic value, as they may correlate with edema volume or myocardial infarct size. However, blood from the coronary sinus is not routinely obtained in the CathLab. As succinate might be also increased in peripheral blood, we aimed to investigate whether peripheral plasma concentrations of succinate and other metabolites obtained during coronary revascularization correlate with edema volume or infarct size in STEMI patients. Plasma samples were obtained from peripheral blood within the first 10 min of revascularization in 102 STEMI patients included in the COMBAT-MI trial (initial TIMI 1) and from 9 additional patients with restituted coronary blood flow (TIMI 2). Metabolite concentrations were analyzed by 1 H-NMR. Succinate concentration averaged 0.069 ± 0.0073 mmol/L in patients with TIMI flow ≤ 1 and was significantly increased in those with TIMI 2 at admission (0.141 ± 0.058 mmol/L, p < 0.05). However, regression analysis did not detect any significant correlation between most metabolite concentrations and infarct size, extent of edema or other cardiac magnetic resonance (CMR) variables. In conclusion, spontaneous reperfusion in TIMI 2 patients associates with enhanced succinate levels in peripheral blood, suggesting that succinate release increases overtime following reperfusion. However, early plasma levels of succinate and other metabolites obtained from peripheral blood does not correlate with the degree of irreversible injury or area at risk in STEMI patients, and cannot be considered as predictors of CMR variables. Trial registration: Registered at (NCT02404376) on 31/03/2015. EudraCT number: 2015-001000-58.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Human lysyl oxidase over-expression enhances baseline cardiac oxidative stress but does not aggravate ros generation or infarct size following myocardial ischemia-reperfusion

  • Valls-Lacalle, Laura|||0000-0002-7185-0454
  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Varona, Saray|||0000-0002-7375-313X
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
Lysyl oxidase (LOX) is an enzyme critically involved in collagen maturation, whose activity releases HO as a by-product. Previous studies demonstrated that LOX over-expression enhances reactive oxygen species (ROS) production and exacerbates cardiac remodeling induced by pressure overload. However, whether LOX influences acute myocardial infarction and post-infarct left ventricular remodeling and the contribution of LOX to myocardial oxidative stress following ischemia-reperfusion have not been analyzed. Isolated hearts from transgenic mice over-expressing human LOX in the heart (TgLOX) and wild-type (WT) littermates were subjected to global ischemia and reperfusion. Although under basal conditions LOX transgenesis is associated with higher cardiac superoxide levels than WT mice, no differences in ROS production were detected in ischemic hearts and a comparable acute ischemia-reperfusion injury was observed (infarct size: 56.24 ± 9.44 vs. 48.63 ± 2.99% of cardiac weight in WT and TgLOX, respectively). Further, similar changes in cardiac dimensions and function were observed in TgLOX and WT mice 28 days after myocardial infarction induced by transient left anterior descending (LAD) coronary artery occlusion, and no differences in scar area were detected (20.29 ± 3.10 vs. 21.83 ± 2.83% of left ventricle). Our data evidence that, although LOX transgenesis induces baseline myocardial oxidative stress, neither ROS production, infarct size, nor post-infarction cardiac remodeling were exacerbated following myocardial ischemia-reperfusion.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test

  • Lema, Camila
  • Aguade Bruix, Santiago
  • Consegal, Marta
  • Ferreira-Gonzalez, Ignacio
  • Barba, Ignasi
  • Andrés Villarreal, Mireia
  • Rodriguez-Sinovas, Antonio
  • Benito, Begoña
Síndromes coronàries agudes; Metabolòmica, Síndromes coronarios agudos; Metabolómica, Acute coronary syndromes; Metabolomics, Cardiovascular diseases are the leading cause of death worldwide. Changes in lifestyle and/or pharmacological treatment are able to reduce the burden of coronary artery diseases (CAD) and early diagnosis is crucial for the timely and optimal management of the disease. Stress testing is a good method to measure the burden of CAD but it is time consuming and pharmacological testing may not fully mimic exercise test. The objectives of the present project were to characterize the metabolic profile of the population undergoing pharmacological and exercise stress testing to evaluate possible differences between them, and to assess the capacity of 1H NMR spectroscopy to predict positive stress testing. Pattern recognition was applied to 1H NMR spectra from serum of patients undergoing stress test and metabolites were quantified. The effects of the stress test, confounding variables and the ability to predict ischemia were evaluated using OPLS-DA. There was an increase in lactate and alanine concentrations in post-test samples in patients undergoing exercise test, but not in those submitted to pharmacological testing. However, when considering only pharmacological patients, those with a positive test result, showed increased serum lactate, that was masked by the much larger amount of lactate associated to exercise testing. In conclusion, we have established that pharmacological stress test does not reproduce the dynamic changes observed in exercise stress. Although there is promising evidence suggesting that 1H NMR based metabolomics could predict stress test results, further studies with much larger populations will be required in order to obtain a definitive answer., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (Grants PI14/01431 and PI17/01397, SGR-1807, CIBER-CV and CIBERESP), co-financed by the European Regional Development Fund (ERDF-FEDER, a way to build Europe).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Angiotensin II-induced cardiomyocyte hypertrophy: A complex response dependent on intertwined pathways, Hipertrofia cardiomiocitária induzida por angiotensina II: Uma resposta complexa dependente de vias entrelaçadas

  • Consegal Perez, Marta
  • Valls de Lacalle, Laura
  • Rodríguez Sinovas, Antonio
Hipertrofia cardiomiocitária, Hipertròfia cardiomiocitària, Cardiomyocyte hypertrophy, This study was supported by the Spanish Ministry of Economy and Competitiveness and Instituto de Salud Carlos III (PI17/01397 and CIBERCV), and cofinanced by the European Regional Development Fund (ERDF, ‘a Way to Build Europe’). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Human Lysyl Oxidase Over-Expression Enhances Baseline Cardiac Oxidative Stress but Does Not Aggravate ROS Generation or Infarct Size Following Myocardial Ischemia-Reperfusion

  • Valls Lacalle, Laura
  • Puertas-Umbert, Lídia
  • Varona, Saray
  • Martínez-González, José
  • Rodríguez Sinovas, Antonio
  • Rodriguez, Cristina
Cardiac remodeling; Lysyl oxidase; Reperfusion injury, Remodelación cardiaca; Lisil oxidasa; Lesión por reperfusión, Remodelació cardíaca; Lisil oxidasa; Lesió de reperfusió, Lysyl oxidase (LOX) is an enzyme critically involved in collagen maturation, whose activity releases H2O2 as a by-product. Previous studies demonstrated that LOX over-expression enhances reactive oxygen species (ROS) production and exacerbates cardiac remodeling induced by pressure overload. However, whether LOX influences acute myocardial infarction and post-infarct left ventricular remodeling and the contribution of LOX to myocardial oxidative stress following ischemia-reperfusion have not been analyzed. Isolated hearts from transgenic mice over-expressing human LOX in the heart (TgLOX) and wild-type (WT) littermates were subjected to global ischemia and reperfusion. Although under basal conditions LOX transgenesis is associated with higher cardiac superoxide levels than WT mice, no differences in ROS production were detected in ischemic hearts and a comparable acute ischemia-reperfusion injury was observed (infarct size: 56.24 ± 9.44 vs. 48.63 ± 2.99% of cardiac weight in WT and TgLOX, respectively). Further, similar changes in cardiac dimensions and function were observed in TgLOX and WT mice 28 days after myocardial infarction induced by transient left anterior descending (LAD) coronary artery occlusion, and no differences in scar area were detected (20.29 ± 3.10 vs. 21.83 ± 2.83% of left ventricle). Our data evidence that, although LOX transgenesis induces baseline myocardial oxidative stress, neither ROS production, infarct size, nor post-infarction cardiac remodeling were exacerbated following myocardial ischemia-reperfusion., This work was supported by the Spanish Instituto de Salud Carlos III (ISCIII) (PI18/0919 and PI17/01397) co-financed by the European Regional Development Fund (ERDF-FEDER, a way to build Europe), the Spanish Ministerio de Ciencia e Innovación (RTI2018-094727-B-100), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2017-SGR-00333 and 2017-SGR-1807) and Fundació La Marató TV3 (grant 2015.3610). A.R.-S. has a consolidated Miguel Servet contract and L.P. is supported by a PFIS contract (ISCIII).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease

  • Rodríguez Sinovas, Antonio
  • Sanchez Garcia, Jose A
  • Valls de Lacalle, Laura
  • Consegal Perez, Marta
  • Ferreira González, Ignacio
Cardiomiòcit; Connexina; Mitocondris, Cardiomiocito; Conexina; Mitocondrias, Cardiomyocyte; Connexin; Mitochondria, Connexins are a family of transmembrane proteins that play a key role in cardiac physiology. Gap junctional channels put into contact the cytoplasms of connected cardiomyocytes, allowing the existence of electrical coupling. However, in addition to this fundamental role, connexins are also involved in cardiomyocyte death and survival. Thus, chemical coupling through gap junctions plays a key role in the spreading of injury between connected cells. Moreover, in addition to their involvement in cell-to-cell communication, mounting evidence indicates that connexins have additional gap junction-independent functions. Opening of unopposed hemichannels, located at the lateral surface of cardiomyocytes, may compromise cell homeostasis and may be involved in ischemia/reperfusion injury. In addition, connexins located at non-canonical cell structures, including mitochondria and the nucleus, have been demonstrated to be involved in cardioprotection and in regulation of cell growth and differentiation. In this review, we will provide, first, an overview on connexin biology, including their synthesis and degradation, their regulation and their interactions. Then, we will conduct an in-depth examination of the role of connexins in cardiac pathophysiology, including new findings regarding their involvement in myocardial ischemia/reperfusion injury, cardiac fibrosis, gene transcription or signaling regulation., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (grants PI17/01397 and CIBERCV), and the Spanish Society of Cardiology (Proyectos de la FEC para Investigación Básica en Cardiología 2018, Sociedad Española de Cardiología), Fundació La Marató de TV3 (Nº. 201536-10) and was cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Serum Metabolomic Analysis Suggests Impairment of Myocardial Energy Production in Takotsubo Syndrome

  • Andres Villarreal, Mireia
  • Benito Villabriga, Begoña
  • Bernardo, Esther
  • Vedia, Oscar
  • Ferreira González, Ignacio
  • Barba Vert, Ignasi
  • Nuñez Gil, Ivan Javier
Acute coronary syndromes; Takotsubo syndrome, Síndromes coronarios agudos; Síndrome de Takotsubo, Síndromes coronaris aguts; Síndrome de Takotsubo, Introduction: Takotsubo syndrome is a complex entity that, although it usually has a good prognosis, can be life threatening. While recent advances have improved the knowledge of takotsubo syndrome, many aspects of its etiology still remain uncertain. Metabolomics, a hypothesis generating approach, could provide novel pathophysiology information about this disease. Methods and Results: Serum samples were obtained from takotsubo (n = 19) and acute myocardial infarction patients (n = 8) at the cath lab and, in the case of takotsubo, again once the patient had recovered, 3 months after the main event. 1H NMR spectra of the serum were acquired at 9.4T using a CPMG pulse sequence (32 ms effective delay). Supervised and unsupervised pattern recognition approaches where applied to the data. Pattern recognition was able to differentiate between takotsubo and acute myocardial infarction during the acute phase with 95% accuracy. Myocardial infarction patients showed an increase in lipid signals, a known risk factor for the disease while takotsubo patients showed a relative increase in acetate that could suggest a reduced turnover of the Krebs cycle. When comparing acute and recovered phases, we could detect an increase in alanine and creatine once patients recovered. Conclusions: Our results demonstrate that takotsubo syndrome is metabolically different than AMI, showing limited myocardial energy production capacity during the acute phase. We achieved high classification success against AMI; however, this study should be considered as a proof of concept regarding clinical application of metabolic profiling in takotsubo cardiomyopathy., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (Grants PI14/01431 and PI17/01397, SGR-1807, CIBER-CV, and CIBERESP), co-financed by the European Regional Development Fund (ERDF-FEDER, a way to build Europe).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Citric Acid Cycle Metabolites Predict Infarct Size in Pigs Submitted to Transient Coronary Artery Occlusion and Treated with Succinate Dehydrogenase Inhibitors or Remote Ischemic Perconditioning

  • Consegal Perez, Marta
  • Núñez, Norberto
  • Barba Vert, Ignasi
  • Benito Villabriga, Begoña
  • Inserte Igual, Javier
  • Ferreira González, Ignacio
  • Rodríguez Sinovas, Antonio
  • Ruiz Meana, Marisol
Isquèmia-reperfusió; Infart de miocardi; Succinat deshidrogenasa, Isquemia-reperfusión; Infarto de miocardio; Succinato deshidrogenasa, Ischemia-reperfusion; Myocardial infarction; Succinate dehydrogenase, Succinate dehydrogenase (SDH) inhibition with malonate during reperfusion reduced myocardial infarction in animals, whereas its endogenous substrate, succinate, is detected in plasma from STEMI patients. We investigated whether protection by SDH inhibition is additive to that of remote ischemic perconditioning (RIC) in pigs submitted to transient coronary artery occlusion, and whether protective maneuvers influence plasma levels of citric acid cycle metabolites. Forty pigs were submitted to 40 min coronary occlusion and reperfusion, and allocated to four groups (controls, sodium malonate 10 mmol/L, RIC, and malonate + RIC). Plasma was obtained from femoral and great cardiac veins and analyzed by LC-MS/MS. Malonate, RIC, and malonate + RIC reduced infarct size (24.67 ± 5.98, 25.29 ± 3.92 and 29.83 ± 4.62% vs. 46.47 ± 4.49% in controls, p < 0.05), but no additive effects were detected. Enhanced concentrations of succinate, fumarate, malate and citrate were observed in controls during initial reperfusion in the great cardiac vein, and most were reduced by cardioprotective maneuvers. Concentrations of succinate, fumarate, and malate significantly correlated with infarct size. In conclusion, despite the combination of SDH inhibition during reperfusion and RIC did not result in additive protection, plasma concentrations of selected citric acid cycle metabolites are attenuated by protective maneuvers, correlate with irreversible injury, and might become a prognosis tool in STEMI patients., This research was funded by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (grants PI17/01397 and CIBERCV) and the Spanish Society of Cardiology (Proyectos de la FEC para Investigación Básica en Cardiología 2018, Sociedad Española de Cardiología), and was cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Spontaneous reperfusion enhances succinate concentration in peripheral blood from stemi patients but its levels does not correlate with myocardial infarct size or area at risk

  • Serra Creus, Bernat
  • Ojeda Ramos, Manuel Tamir
  • Carmona, Maria Angeles
  • Lidón Corbi, Rosa María
  • Inserte Igual, Javier
  • Ferreira González, Ignacio
  • Martí Aguasca, Gerard
  • Valente, Filipa
  • Ruiz Meana, Marisol
  • miro casas, elisabet
  • Rodriguez-Sinovas, Antonio
  • García del Blanco, Bruno
  • Barrabés, José A.
  • Rodríguez Palomares, Jose Fernando
  • Sambola Ayala, Antonia
  • Benito, Begoña
  • Consegal, Marta
  • Barba, Ignasi
  • Bañeras, Jordi
  • Otaegui Irurueta, Imanol
  • Bellera Gotarda, Neus
Cardiovascular biology; Diagnostic markers; Prognostic markers, Biología cardiovascular; Marcadores de diagnóstico; Marcadores pronósticos, Biologia cardiovascular; Marcadors diagnòstics; Marcadors pronòstics, Succinate is enhanced during initial reperfusion in blood from the coronary sinus in ST-segment elevation myocardial infarction (STEMI) patients and in pigs submitted to transient coronary occlusion. Succinate levels might have a prognostic value, as they may correlate with edema volume or myocardial infarct size. However, blood from the coronary sinus is not routinely obtained in the CathLab. As succinate might be also increased in peripheral blood, we aimed to investigate whether peripheral plasma concentrations of succinate and other metabolites obtained during coronary revascularization correlate with edema volume or infarct size in STEMI patients. Plasma samples were obtained from peripheral blood within the first 10 min of revascularization in 102 STEMI patients included in the COMBAT-MI trial (initial TIMI 1) and from 9 additional patients with restituted coronary blood flow (TIMI 2). Metabolite concentrations were analyzed by 1H-NMR. Succinate concentration averaged 0.069 ± 0.0073 mmol/L in patients with TIMI flow ≤ 1 and was significantly increased in those with TIMI 2 at admission (0.141 ± 0.058 mmol/L, p < 0.05). However, regression analysis did not detect any significant correlation between most metabolite concentrations and infarct size, extent of edema or other cardiac magnetic resonance (CMR) variables. In conclusion, spontaneous reperfusion in TIMI 2 patients associates with enhanced succinate levels in peripheral blood, suggesting that succinate release increases overtime following reperfusion. However, early plasma levels of succinate and other metabolites obtained from peripheral blood does not correlate with the degree of irreversible injury or area at risk in STEMI patients, and cannot be considered as predictors of CMR variables. Trial registration: Registered at www.clinicaltrials.gov (NCT02404376) on 31/03/2015. EudraCT number: 2015-001000-58., This work was supported by the Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (Grants PI17/01397 and CIBERCV) and the Spanish Society of Cardiology (Proyectos de la FEC para Investigación Básica en Cardiología 2018, Sociedad Española de Cardiología), and was cofinanced by the European Regional Development Fund (ERDF-FEDER, a way to build Europe). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract.